Decoding Altered States. Re-defining Mental Health and Consciousness.
Current models dismiss psychedelic states as "mere hallucinations," rendering them unpredictable and subjective. Because this profound dimension remains unmapped, scaling these therapies safely is impossible without a standardized, intelligent framework.
A rapidly expanding multi-billion dollar market driven by FDA breakthroughs, shifting legal frameworks, and an unprecedented demand for novel mental health interventions.
By mapping the unified dimension, our foundational patent creates a profound defensible moat. We are expanding the market beyond clinical illness to provide breakthrough cognitive enhancement and universal human empowerment.
Beyond mental health treatment. Entity is a foundational technology for exploring and expanding human consciousness. We are building the operating system for the mind's future.
A significant federal shift as the administration acts to expedite psychedelic drug reviews...
New developments in Veterans Affairs clinical trials investigating the efficacy...
A landmark moment for clinical psychedelic therapy as active-duty soldiers are approved...
Nature Neuropsychopharmacology publishes a comprehensive review of clinical psychedelic therapies...
A closer look at the controversies surrounding clinical trials and the importance of stringent ethical protocols.